Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$192.5 - $216.35 $89,512 - $100,602
-465 Reduced 5.26%
8,381 $1.71 Million
Q1 2024

Apr 17, 2024

BUY
$209.01 - $232.56 $58,522 - $65,116
280 Added 3.27%
8,846 $1.93 Million
Q4 2023

Jan 23, 2024

SELL
$197.69 - $227.29 $2.67 Million - $3.07 Million
-13,518 Reduced 61.21%
8,566 $1.95 Million
Q3 2023

Oct 24, 2023

SELL
$201.05 - $221.7 $17,491 - $19,287
-87 Reduced 0.39%
22,084 $4.44 Million
Q2 2023

Aug 09, 2023

SELL
$211.93 - $241.33 $116,561 - $132,731
-550 Reduced 2.42%
22,171 $5.35 Million
Q1 2023

May 08, 2023

BUY
$213.32 - $257.83 $82,341 - $99,522
386 Added 1.73%
22,721 $5.21 Million
Q4 2022

Feb 09, 2023

BUY
$203.72 - $248.97 $74,357 - $90,874
365 Added 1.66%
22,335 $5.26 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $14,336 - $18,353
-70 Reduced 0.32%
21,970 $4.5 Million
Q2 2022

Jul 22, 2022

SELL
$213.86 - $277.87 $27,587 - $35,845
-129 Reduced 0.58%
22,040 $5.17 Million
Q1 2022

May 04, 2022

BUY
$259.82 - $298.18 $163,686 - $187,853
630 Added 2.92%
22,169 $5.85 Million
Q4 2021

Jan 27, 2022

BUY
$271.6 - $314.21 $26,616 - $30,792
98 Added 0.46%
21,539 $6.77 Million
Q3 2021

Oct 15, 2021

SELL
$274.82 - $308.34 $269,323 - $302,173
-980 Reduced 4.37%
21,441 $5.87 Million
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $225,675 - $249,213
896 Added 4.16%
22,421 $6.19 Million
Q1 2021

Apr 28, 2021

BUY
$204.88 - $255.03 $337,437 - $420,034
1,647 Added 8.29%
21,525 $5.49 Million
Q4 2020

Feb 04, 2021

BUY
$186.91 - $214.42 $41,680 - $47,815
223 Added 1.13%
19,878 $4.05 Million
Q3 2020

Nov 13, 2020

BUY
$167.03 - $201.3 $62,302 - $75,084
373 Added 1.93%
19,655 $3.7 Million
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $90,761 - $146,134
801 Added 4.33%
19,282 $3.2 Million
Q1 2020

May 12, 2020

BUY
$104.32 - $195.28 $227,626 - $426,100
2,182 Added 13.39%
18,481 $2.34 Million
Q4 2019

Feb 10, 2020

SELL
$163.48 - $173.61 $55,583 - $59,027
-340 Reduced 2.04%
16,299 $2.76 Million
Q3 2019

Nov 12, 2019

SELL
$159.77 - $178.1 $41,540 - $46,306
-260 Reduced 1.54%
16,639 $2.8 Million
Q2 2019

Aug 12, 2019

BUY
$144.16 - $172.9 $138,537 - $166,156
961 Added 6.03%
16,899 $2.92 Million
Q1 2019

May 09, 2019

BUY
$123.7 - $156.3 $41,192 - $52,047
333 Added 2.13%
15,938 $2.44 Million
Q4 2018

Feb 07, 2019

SELL
$120.82 - $174.09 $115,987 - $167,126
-960 Reduced 5.8%
15,605 $1.97 Million
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $1.24 Million - $1.39 Million
7,400 Added 80.74%
16,565 $2.88 Million
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $419,262 - $495,307
2,615 Added 39.92%
9,165 $1.65 Million
Q3 2017

Oct 18, 2017

BUY
$149.47 - $160.56 $979,028 - $1.05 Million
6,550
6,550 $989,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Baker Ellis Asset Management LLC Portfolio

Follow Baker Ellis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Ellis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Ellis Asset Management LLC with notifications on news.